Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Flam

Showing results (91-100 of 104) with videos related to

Pageof 11
Sort By:
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|March 22, 2003
[CT and MR image fusion using two different methods after prostate brachytherapy: impact on post-implant dosimetric assessment]V Servois, L Chauveinc, C El Khoury, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|February 24, 2001
[In vitro study of the modulation of human ureteral tonus by nitric oxide and zaprinast, a phosphodiesterase inhibitor]D Saighi, M Zerbib, N Thiounn, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|December 2, 2008
[Testicular implants, patient's and partner's satisfaction: a questionnaire-based study of men after orchidectomy]E Xylinas, G Martinache, V Azancot, et al.
Clinical and Translational Radiation Oncology|July 19, 2024
Salvage low-dose-rate brachytherapy for locally recurrent prostate cancer after definitive irradiationY Meraouna, P Blanchard, S Losa, et al.
AJR. American Journal of Roentgenology|September 23, 2000
Endorectal color doppler sonography and endorectal MR imaging features of nonpalpable prostate cancer: correlation with radical prostatectomy findingsF Cornud, K Hamida, T Flam, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|November 27, 2013
[Prognostic factors of upper tract urothelial carcinoma]V Elalouf, J Klap, N-B Delongchamps, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
Non-cytotoxic CD4 tumour-infiltrating lymphocytes induce responses in patients with metastatic renal cell carcinoma previously treated with interleukin-2C Mathiot, N Thiounn, E Tartour, et al.
Immunology Letters|July 1, 1997
IL-6 is a survival prognostic factor in renal cell carcinomaN Thiounn, F Pages, T Flam, et al.
Urology|May 1, 1997
Color Doppler-guided prostate biopsies in 591 patients with an elevated serum PSA level: impact on Gleason score for nonpalpable lesionsF Cornud, X Belin, D Piron, et al.
Journal D'Urologie|January 1, 1994
[CD4 TIL (Tumor Infiltrating Lymphocytes) induce complete response in patients treated with IL-2 (Interleukin-2). Preliminary study]N Thiounn, C Mathiot, T Flam, et al.
Pageof 11

Showing results (91-100 of 104) with videos related to

Sort By:
Pageof 11
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|March 22, 2003
[CT and MR image fusion using two different methods after prostate brachytherapy: impact on post-implant dosimetric assessment]V Servois, L Chauveinc, C El Khoury, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|February 24, 2001
[In vitro study of the modulation of human ureteral tonus by nitric oxide and zaprinast, a phosphodiesterase inhibitor]D Saighi, M Zerbib, N Thiounn, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|December 2, 2008
[Testicular implants, patient's and partner's satisfaction: a questionnaire-based study of men after orchidectomy]E Xylinas, G Martinache, V Azancot, et al.
Clinical and Translational Radiation Oncology|July 19, 2024
Salvage low-dose-rate brachytherapy for locally recurrent prostate cancer after definitive irradiationY Meraouna, P Blanchard, S Losa, et al.
AJR. American Journal of Roentgenology|September 23, 2000
Endorectal color doppler sonography and endorectal MR imaging features of nonpalpable prostate cancer: correlation with radical prostatectomy findingsF Cornud, K Hamida, T Flam, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|November 27, 2013
[Prognostic factors of upper tract urothelial carcinoma]V Elalouf, J Klap, N-B Delongchamps, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
Non-cytotoxic CD4 tumour-infiltrating lymphocytes induce responses in patients with metastatic renal cell carcinoma previously treated with interleukin-2C Mathiot, N Thiounn, E Tartour, et al.
Immunology Letters|July 1, 1997
IL-6 is a survival prognostic factor in renal cell carcinomaN Thiounn, F Pages, T Flam, et al.
Urology|May 1, 1997
Color Doppler-guided prostate biopsies in 591 patients with an elevated serum PSA level: impact on Gleason score for nonpalpable lesionsF Cornud, X Belin, D Piron, et al.
Journal D'Urologie|January 1, 1994
[CD4 TIL (Tumor Infiltrating Lymphocytes) induce complete response in patients treated with IL-2 (Interleukin-2). Preliminary study]N Thiounn, C Mathiot, T Flam, et al.
Pageof 11